These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35681563)

  • 1. Model Cell Lines and Tissues of Different HGSOC Subtypes Differ in Local Estrogen Biosynthesis.
    Pavlič R; Gjorgoska M; Rižner TL
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting estrogen metabolism in high-grade serous ovarian cancer shows promise to overcome platinum resistance.
    Marolt N; Pavlič R; Kreft T; Gjogorska M; Rižner TL
    Biomed Pharmacother; 2024 Aug; 177():117069. PubMed ID: 38968802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo tumor growth of high-grade serous ovarian cancer cell lines.
    Mitra AK; Davis DA; Tomar S; Roy L; Gurler H; Xie J; Lantvit DD; Cardenas H; Fang F; Liu Y; Loughran E; Yang J; Sharon Stack M; Emerson RE; Cowden Dahl KD; V Barbolina M; Nephew KP; Matei D; Burdette JE
    Gynecol Oncol; 2015 Aug; 138(2):372-7. PubMed ID: 26050922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of a panel of high-grade serous ovarian cancer cell lines as representative experimental models of the disease.
    Haley J; Tomar S; Pulliam N; Xiong S; Perkins SM; Karpf AR; Mitra S; Nephew KP; Mitra AK
    Oncotarget; 2016 May; 7(22):32810-20. PubMed ID: 27147568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes.
    Barnes BM; Nelson L; Tighe A; Burghel GJ; Lin IH; Desai S; McGrail JC; Morgan RD; Taylor SS
    Genome Med; 2021 Sep; 13(1):140. PubMed ID: 34470661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond genomics: critical evaluation of cell line utility for ovarian cancer research.
    Elias KM; Emori MM; Papp E; MacDuffie E; Konecny GE; Velculescu VE; Drapkin R
    Gynecol Oncol; 2015 Oct; 139(1):97-103. PubMed ID: 26321251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer.
    Mungenast F; Aust S; Vergote I; Vanderstichele A; Sehouli J; Braicu E; Mahner S; Castillo-Tong DC; Zeillinger R; Thalhammer T
    Oncol Lett; 2017 Jun; 13(6):4047-4054. PubMed ID: 28588698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions.
    Alkema NG; Wisman GB; van der Zee AG; van Vugt MA; de Jong S
    Drug Resist Updat; 2016 Jan; 24():55-69. PubMed ID: 26830315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of estrogen response-associated STRA6+ granulosa cells within high-grade serous ovarian carcinoma by single-cell sequencing.
    Liu X; Chen Z; Zhang L
    Heliyon; 2024 Mar; 10(6):e27790. PubMed ID: 38509903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of ovarian high-grade serous carcinoma cell lines that show estrogen-sensitive growth as xenografts in immunocompromised mice.
    De Haven Brandon A; Box G; Hallsworth A; Court W; Matthews N; Herodek B; Arteagabeitia AB; Valenti M; Kirkin V
    Sci Rep; 2020 Jul; 10(1):10799. PubMed ID: 32612269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization of Carboplatinum- and Taxol-Resistant High-Grade Serous Ovarian Cancer Cells Carrying p53, BRCA1/2 Mutations by Emblica officinalis (Amla) via Multiple Targets.
    De A; De A; Sharma R; Suo W; Sharma M
    J Cancer; 2020; 11(7):1927-1939. PubMed ID: 32194804
    [No Abstract]   [Full Text] [Related]  

  • 12. In the Model Cell Lines of Moderately and Poorly Differentiated Endometrial Carcinoma, Estrogens Can Be Formed
    Pavlič R; Gjorgoska M; Hafner E; Sinreih M; Gajser K; Poschner S; Jäger W; Rižner TL
    Front Mol Biosci; 2021; 8():743403. PubMed ID: 34805270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
    Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
    J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endometrial cancer cell lines Ishikawa and HEC-1A, and the control cell line HIEEC, differ in expression of estrogen biosynthetic and metabolic genes, and in androstenedione and estrone-sulfate metabolism.
    Hevir-Kene N; Rižner TL
    Chem Biol Interact; 2015 Jun; 234():309-19. PubMed ID: 25437045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural compound n-butylidenephthalide kills high-grade serous ovarian cancer stem cells by activating intrinsic apoptosis signaling pathways.
    Chang YH; Wu KC; Ding DC
    J Cancer; 2021; 12(11):3126-3135. PubMed ID: 33976722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of Estrogens: Turnover Differs Between Platinum-Sensitive and -Resistant High-Grade Serous Ovarian Cancer Cells.
    Poschner S; Wackerlig J; Castillo-Tong DC; Wolf A; Decken IV; Rižner TL; Pavlič R; Meshcheryakova A; Mechtcheriakova D; Fritzer-Szekeres M; Thalhammer T; Jäger W
    Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31979221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a relationship in-between ovarian endometriosis and ovarian cancer? Immunohistochemical profile of four cases with coexisting ovarian endometriosis and cancer.
    Penciu RC; Postolache I; Steriu L; Izvoranu S; Tica AA; Mocanu ID; Sârbu V; Deacu M; Tica I; Bălţătescu GI; Tica OS; Tica VI
    Rom J Morphol Embryol; 2020; 61(1):157-165. PubMed ID: 32747907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance.
    Sheets JN; Iwanicki M; Liu JF; Howitt BE; Hirsch MS; Gubbels JA; Drapkin R; Egland KA
    Oncogenesis; 2016 Oct; 5(10):e264. PubMed ID: 27775699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylomic Signatures of High Grade Serous Ovarian Cancer.
    Cardenas H; Fang F; Jiang G; Perkins SM; Zhang C; Emerson RE; Hutchins G; Keer HN; Liu Y; Matei D; Nephew K
    Epigenetics; 2021 Nov; 16(11):1201-1216. PubMed ID: 33289590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Significance of the Sulfatase Pathway for Local Estrogen Formation in Endometrial Cancer.
    Sinreih M; Knific T; Anko M; Hevir N; Vouk K; Jerin A; Frković Grazio S; Rižner TL
    Front Pharmacol; 2017; 8():368. PubMed ID: 28690541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.